These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1133815)

  • 1. Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists.
    Heilman RD; Hahn EF; Fishman J
    J Med Chem; 1975 Mar; 18(3):259-62. PubMed ID: 1133815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the hot plate technique to study narcotic antagonists.
    Heilman RD; Gray MI; Chen RP; Hahn EF; Fishman J
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):635-47. PubMed ID: 1265343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone.
    Jiang JB; Hanson RN; Portoghese PS; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
    Bianchi G; Fiocchi R; Tavani A; Manara L
    Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558).
    Fujimoto JM; Roerig S; Wang RI; Chatterjie N; Inturrisi CE
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):443-8. PubMed ID: 1168347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
    O'Callaghan JP; Holtzman SG
    J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.
    Chatterjie N; Inturrisi CE
    J Med Chem; 1975 May; 18(5):490-2. PubMed ID: 1151958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone, naltrexone, and related noroxymorphones.
    Blumberg H; Dayton HB
    Adv Biochem Psychopharmacol; 1973; 8(0):33-43. PubMed ID: 4794989
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone.
    Tulunay FC; Yano I; Takemori AE
    Eur J Pharmacol; 1976 Feb; 35(2):285-92. PubMed ID: 1248505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and stereochemical identification of a metabolite of naltrexone from human urine.
    Chatterjie N; Fujimoto JM; Inturrisi CE; Roerig S; Wang RI; Bowen DV; Field FH; Clarke DD
    Drug Metab Dispos; 1974; 2(5):401-5. PubMed ID: 4156301
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity.
    Friedmann T; Tóth Z; Hosztafi S; Simon CS; Makleit S; Fürst S
    Arch Int Pharmacodyn Ther; 1994; 328(1):16-25. PubMed ID: 7893188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcotic antagonists. 1. Isomeric sulfate and acetate esters of naloxone (N-allylnoroxymorphone).
    Linder C; Fishman J
    J Med Chem; 1973 May; 16(5):553-6. PubMed ID: 4718473
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirobutenolides substituted by arylpiperazinyl-carbonyl moieties. Synthesis and antinociceptive properties.
    Bois F; Moreau S; Coudert P; Rubat C; Couquelet J
    Arzneimittelforschung; 1998 Dec; 48(12):1156-62. PubMed ID: 9893930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
    Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
    Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone, morphine and cocaine interactions in mice and rats.
    Blumberg H; Ikeda C
    J Pharmacol Exp Ther; 1978 Aug; 206(2):303-10. PubMed ID: 682114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphine antibodies in the mechanisms of morphine resistance, morphine tolerance and of the action of an antagonist].
    Kaliuzhnyĭ LV; Litvinova SV; Kaliuzhnyĭ AL; Aristova VV; Gruden' MA; Kozlov AIu; Torgovanova GV; Fedoseeva OV
    Eksp Klin Farmakol; 1998; 61(1):21-4. PubMed ID: 9575406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.